Stocks · News reference
Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), a diversified preparedness, logistics, and critical-infrastructure company, today announced progress toward establishing domestic
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Callan JMB Inc. has entered into an agreement to install a production line for Rapid Dose Therapeutics' QuickStrip™ oral thin-film technology, projecting $15 million in revenue over the first 18 months.
Callan JMB has received a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics for installation at its Texas facility. The company projects $15 million in revenue over the next 18 months from this new pharmaceutical manufacturing platform, advancing its strategy to expand domestic pharmaceutical manufacturing and healthcare logistics capabilities.
Gainers GrafTech International (NYSE:EAF) stock moved upwards by 33.1% to $11.32 during Monday's regular session. The company's market cap stands at $200.3 million. The company's, Q3 earnings came out
Callan JMB Inc. CEO Wayne Williams announced that a new facility is fully funded by a third-party investment, ensuring no additional debt or shareholder dilution.
Rapid Dose Therapeutics has delivered a complete QuickStrip production line to Callan JMB, marking a significant step in their manufacturing collaboration.
Callan JMB Inc. announced plans to introduce approximately 2,800 units at the Atlas Complex in Alabama.